Cargando…
Anesthesia for muscle biopsy to test susceptibility to malignant hyperthermia
INTRODUCTION: Malignant hyperthermia is an autosomal dominant pharmacogenetic disorder, characterized by hypermetabolic crisis triggered by halogenated anesthetics and/or succinylcholine. The standard method for diagnosing malignant hyperthermia susceptibility is the in vitro muscle contracture test...
Autores principales: | Silva, Helga Cristina Almeida da, Onari, Elton Shinji, Castro, Isac de, Perez, Marcelo Vaz, Hortensi, Alexandre, Amaral, José Luiz Gomes do |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391910/ https://www.ncbi.nlm.nih.gov/pubmed/31053363 http://dx.doi.org/10.1016/j.bjane.2019.02.003 |
Ejemplares similares
-
Profile of malignant hyperthermia susceptibility reports confirmed with muscular contracture test in Brazil
por: Silva, Helga Cristina Almeida da, et al.
Publicado: (2019) -
Impact of a digital manual for guidance on malignant hyperthermia: patient education
por: Rodrigues, Gislene, et al.
Publicado: (2022) -
Atypical reaction to anesthesia in Duchenne/Becker muscular dystrophy
por: Silva, Helga Cristina Almeida da, et al.
Publicado: (2017) -
Evaluation of dexmedetomidine anesthesia-related temperature changes: preliminary retrospective observational study
por: Cruz, Felipe Aparecido Ferreira da, et al.
Publicado: (2021) -
Carnitine palmitoyltransferase 2 deficiency, malignant hyperthermia and anesthesia
por: Glauber, Violeta, et al.
Publicado: (2014)